BioCentury
ARTICLE | Financial News

TG Therapeutics completes follow-on

March 10, 2017 8:11 PM UTC

On March 9, cancer and autoimmune company TG Therapeutics Inc. (NASDAQ:TGTX) raised $50 million through the sale of 5.1 million shares at $9.75 in a follow-on underwritten by Jefferies, SunTrust, Lad...

BCIQ Company Profiles

TG Therapeutics Inc.